Rwanda

in page functions
[French]
Rwanda
Total population (2016) 11,882,752
Birth cohort (2016) 363,074
Surviving Infants (surviving to 1 year per year, 2016) 346,991
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 31/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 42/1000
World Bank Index, IDA (2012) 3.84
Co-financing status (2016) Initial self-financing
No. of districts/territories (2015) 30

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Rwanda

Type of support

Approvals

2001-2021 (US$)
(20 Dec 2016)

Commitments

2001-2021 (US$)
(20 Dec 2016)

Disbursements

2000-2016 (US$)
(20 Dec 2016)

% Disbursed

(20 Dec 2016)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Total $143,434,205 $145,404,990 $129,803,093
Health system strengthening (HSS 1) $5,605,000 $5,605,000 $5,605,000 100%
Health system strengthening (HSS 2) $10,337,185 $12,307,970 $4,439,957 43%
HPV (NVS) $6,065,546 $6,065,546 $4,718,860 78%
Immunisation services support (ISS) $2,958,700 $2,958,700 $2,958,700 100%
Injection Safety Devices (NVS) $164,500 $164,500
Injection safety support (INS) $369,500 $369,500 $369,500 100%
IPV (NVS) $1,089,872 $1,089,872 $49,125 5%
Measles (NVS) $430,500 $430,500 $157,614 37%
Measles-Rubella (NVS) $3,549,500 $3,549,500 $3,622,489 102%
MR - Operational costs (OPC) $3,279,500 $3,279,500 $3,279,500 100%
Penta (NVS) $46,754,618 $46,754,618 $45,915,488 98%
Pneumo (NVS) $34,098,948 $34,098,948 $33,273,174 98%
Rotavirus (NVS) $27,044,186 $27,044,186 $24,010,035 89%
Vaccine Introduction Grant (VIG) $1,686,650 $1,686,650 $1,403,650 83%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Rwanda DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2015)

Grade of confidence


N/A
DTP3 - Official country estimates (2015) 99%
M:F sex ratio at birth (2016) 1.02
Household survey: DTP3 coverage for male (2009) 97.10%
Household survey: DTP3 coverage for female (2009) 96.50%
Household survey: Last DTP3 survey (2009) 97%
% districts achieving > 80% DTP3 coverage (2015) 117%
% districts achieving < 50% DTP3 coverage (2015) 0%
MCV WHO/UNICEF estimates (2015) 97%

Breakdown of support

Non-vaccine support Vaccine support
14% 86%
$18,056,307 $111,746,783

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Rwanda

08 December 2016

Syrian children

Gavi to support immunisation of children in Syria

Gavi Board decisions also taken to strengthen emergency vaccine stockpiles and to accelerate human papillomavirus (HPV) vaccine programme to protect 40 million girls against cervical cancer by 2020.

14 October 2016

Benin LOGIVAC

Africa takes second “step” toward strengthening supply chain management

New Strategic Training Executive Programme opens at Benin’s LOGIVAC+ Centre, 12 months after similar course offered in Rwanda

14 October 2016

Zipline Delivery 1
close icon

modal window here